COVID-19 Pandemic Increased Interest, Exposed Design Biases of Wearables in Vulnerable Populations
Designs of existing wearables overlook the specific needs of vulnerable populations, hindering their widespread adoption among increasingly interested communities.
Mental Health Awareness Month: Resources Roundup
Check out this list of resources to share with patients who are experiencing mental health conditions.
Slideshow: Exercise May Fight Depression, Mindfulness Could Help Reduce Drug Use
With the mental health crisis worsening in the United States, recent research explores novel treatments and underlying causes.
Exploring the Expanded Potential of GLP-1s
As demand for GLP-1 receptor agonist medications increases, researchers are hopeful these drugs can be used for more indications than those that currently exist.
FDA Approves Oral Treatment for Postpartum Depression
Last August, zuranolone (Zurzuvae) became the first FDA-approved pill to treat postpartum depression in adults.
OTC Product Roundup: Skin Care
Spring and summer not only bring sunshine, but also stronger UV rays. Whether you are barbecuing, swimming, or taking a hike, skin protection is paramount while soaking up the sunshine.
Fentanyl Education, Prevention Key to Ending Crisis in US
For National Fentanyl Awareness Day, Drug Topics talked with Scott H. Silverman about how public health leaders can address the fentanyl crisis and the best ways to educate the public on the dangers of fentanyl use.
FDA Advisory Committee Will Soon Meet to Discuss MDMA-Assisted Therapy for PTSD
The Psychopharmacologic Drugs Advisory Committee will meet June 4 to review a new drug application from Lykos Therapeutics.
In This Issue: Drug Topics May 2024
See what's trending in pharmacy with a preview the Drug Topics May issue.
Slideshow: The Gut-Skin Connection
Recent research exploring the gut-skin connection shows that dietary modifications and probiotic supplements may help skin conditions like acne, atopic dermatitis, and rosacea.
Q&A: Navigating the Exponential Growth of Specialty Drugs
The specialty drug market has exploded in the last few decades.
Asembia: Pharmacists Have a Role in Health Care System Sustainability
As medication experts, pharmacists can advocate to organizational decision makers around the benefits of biosimilars.
Q&A: Understanding Future Impacts of the IRA
Data from 2024 are being used as a way to predict what changes may be on the way for 2025.
FDA Approves Myhibbin for Prophylaxis of Organ Rejection in Adult, Pediatric Transplant Recipients
Mycophenolate mofetil oral suspension is the only FDA-approved ready-to-use liquid formulation.
Specialty Drug Distribution Sensitive to Regulatory Changes: Video
The market is sensitive to both upstream and downstream pressures that impact drug pricing.
Specialty Drug Market Continues Upward Growth Trend
The specialty drug market has exploded, and will continue to grow across sectors such as oncology and neurology.
US Syphilis Cases Continue to Rise as Rare Symptoms Surface
Researchers continue to report on the rise of syphilis in the US, with recent cases exhibiting rare symptoms in the eyes, ears, and brain.
Weekend ICYMI: April 29 to May 3
In case you missed it, this week we had news about marijuana reclassification, the Change Healthcare cyberattack, declining wages among community pharmacists, and more.
Small Doses: April 29 to May 3
Check out a recap of important pharmacy news you might’ve missed this week, dispensed in small doses.
FDA Roundup: Humira Biosimilar, WHIM Syndrome Treatment
Check out important updates from the FDA for the week of April 29.
Video: The Inflation Reduction Act in 2024 and Beyond
A lack of clarity around certain provisions of the Inflation Reduction Act has presented challenges to payers.
Brexpiprazole Plus Sertraline for PTSD Submitted to FDA for sNDA Review
Two trials studying brexpiprazole in combination with sertraline "constitute one of the largest clinical development programs ever conducted in posttraumatic stress disorder (PTSD)."
OTC Product Roundup: In a Galaxy Far, Far Away…
Are you a Wookie with a mane to maintain or a scoundrel prone to nausea? You don’t have to traverse distant planets to find OTC recommendations that meet your needs—this guide has you covered.
Q&A: Inside the Vanderbilt Specialty Pharmacy-AstraZeneca Collaboration
A siloed approach to care can worsen patient outcomes, but collaboration between one health system specialty pharmacy and a manufacturer led to better patient care.
Pharmacogenetic Testing Recommendations Needed in Clinical Guidelines to Increase Consistency
A review found that many guidelines that recommended pharmacogenetic testing were inconsistent between clinical associations.
Goal Alignment Improves Pharmacist-Manufacturer Collaborations, Care
Understanding the goals of each party is the first step to a successful collaboration.
Real World Data Show That Pharmacist-Manufacturer Collaboration Improves Patient Outcomes
Collaboration between health system specialty pharmacists and pharmaceutical manufacturers can benefit patients in the long run.
Weight-Loss Drugs Fuel Rise in US Prescription Spending
The rise of weight-loss drugs has overtaken the US prescription drug market and significantly increased spending from 2022 to 2023.
CGM Use Linked to Improved Diabetic Retinopathy Outcomes in T1D
The current study highlights the potential benefit of incorporating continuous glucose monitor (CGM) data into eye care assessments for patients with type 1 diabetes (T1D).
Hurdles In Access: Costly Switch Studies Block Wider Biosimilar Use
Addressing requirements around FDA interchangeability designations can increase the adoption of biosimilar substitutions at the pharmacy level.